中基健康
(000972)
| 流通市值：27.84亿 | | | 总市值：27.84亿 |
| 流通股本：7.71亿 | | | 总股本：7.71亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 287,695,442.16 | 196,809,756.29 | 54,821,851.96 | 492,115,607.53 |
| 营业收入 | 287,695,442.16 | 196,809,756.29 | 54,821,851.96 | 492,115,607.53 |
| 二、营业总成本 | 390,865,012.73 | 267,349,675.09 | 76,544,878.06 | 675,945,880.11 |
| 营业成本 | 341,939,391.96 | 235,802,669.95 | 53,917,437.4 | 569,191,946.09 |
| 税金及附加 | 1,917,285.35 | 1,681,187.72 | 36,001.94 | 9,256,147.47 |
| 销售费用 | 1,880,967.41 | 1,404,413.37 | 594,578.21 | 5,898,050.23 |
| 管理费用 | 26,525,037.17 | 17,985,175.32 | 12,557,418.06 | 43,893,236.14 |
| 研发费用 | 1,588,524.54 | 1,094,564.16 | 150,005.98 | 2,051,838.82 |
| 财务费用 | 17,013,806.3 | 9,381,664.57 | 9,289,436.47 | 45,654,661.36 |
| 其中:利息费用 | 15,625,982.69 | 8,389,778.79 | 8,825,061.47 | 45,196,984.06 |
| 其中:利息收入 | 272,163.62 | 216,670.51 | -134,438.23 | 359,485.72 |
| 三、其他经营收益 | | | | |
| 资产处置收益 | -337,666.68 | -337,666.68 | -18,167.49 | 3,388,130.74 |
| 资产减值损失(新) | -23,368,581.3 | 515.05 | - | -159,716,007.53 |
| 信用减值损失(新) | -258,168.39 | -563,924.01 | 586,241.04 | 5,965,495.51 |
| 其他收益 | 3,435,919.54 | 2,116,134 | 1,075,021.61 | 285,413,340.15 |
| 四、营业利润 | -123,698,067.4 | -69,324,860.44 | -20,079,930.94 | -48,779,313.71 |
| 加:营业外收入 | 22,887.1 | 7,386.47 | 3,485.39 | 222,850.92 |
| 减:营业外支出 | 300,967.82 | 196,442.69 | 189,705.05 | 3,214,447.37 |
| 五、利润总额 | -123,976,148.12 | -69,513,916.66 | -20,266,150.6 | -51,770,910.16 |
| 减:所得税费用 | 64,837.91 | -1,322,282.91 | 108,794.99 | 4,261,835.8 |
| 六、净利润 | -124,040,986.03 | -68,191,633.75 | -20,374,945.59 | -56,032,745.96 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -124,040,986.03 | -68,191,633.75 | -20,374,945.59 | -56,032,745.96 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -119,797,095.31 | -65,919,041.3 | -19,629,518.37 | -46,231,823.92 |
| 少数股东损益 | -4,243,890.72 | -2,272,592.45 | -745,427.22 | -9,800,922.04 |
| 扣除非经常损益后的净利润 | -129,492,522.7 | -74,659,960.89 | -20,500,202.83 | -293,203,459.03 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.16 | -0.09 | -0.03 | -0.06 |
| (二)稀释每股收益 | -0.16 | -0.09 | -0.03 | -0.06 |
| 八、其他综合收益 | - | - | - | -277,831.54 |
| 归属于母公司股东的其他综合收益 | - | - | - | -277,831.54 |
| 九、综合收益总额 | -124,040,986.03 | -68,191,633.75 | -20,374,945.59 | -56,310,577.5 |
| 归属于母公司股东的综合收益总额 | -119,797,095.31 | -65,919,041.3 | -19,629,518.37 | -46,509,655.46 |
| 归属于少数股东的综合收益总额 | -4,243,890.72 | -2,272,592.45 | -745,427.22 | -9,800,922.04 |
| 公告日期 | 2026-10-27 | 2026-08-29 | 2026-04-25 | 2026-04-17 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |